In short
This article explores a clinical trial investigating the use of andexanet alfa, a drug designed to reverse the anticoagulation effects of factor Xa inhibitors in patients requiring urgent surgery. The study aims to assess the safety and effectiveness of andexanet alfa compared to usual care in reducing bleeding risk during surgical procedures for patients taking anticoagulants like apixaban, rivaroxaban, or edoxaban.
At a glance
- Study Type
- Phase 3 Interventional trial
- Main Objective
- Assess andexanet's ability to achieve effective intraoperative hemostasis compared to usual care
- Key Inclusion Criteria
- Patients on FXa inhibitors needing urgent surgery within 12 hours, high bleeding risk
- Key Exclusion Criteria
- Acute life-threatening bleeding, bleeding disorders, recent andexanet alfa use
- Treatment Groups
- Andexanet alfa group vs. Usual care group
- Primary Endpoint
- Effective intraoperative hemostasis
- Secondary Endpoints
- Changes in anti-FXa activity at surgery start and 2 hours post-start
- Follow-up Period
- 4 visits over approximately 30 days, with possible additional test at 120 days
What Are Blood and Related Products?
Blood and related products are medical treatments derived from human blood or created to mimic components of blood. These products are essential in various medical situations, particularly when a patient is experiencing bleeding or requires support for their blood system.
Uses of Blood and Related Products
Blood and related products are used in a wide range of medical scenarios, including:
- Treating blood loss during surgery or after injury
- Managing bleeding disorders
- Supporting patients undergoing chemotherapy
- Helping patients with certain chronic diseases
- Reversing the effects of blood-thinning medications (anticoagulants)
Types of Blood and Related Products
There are several types of blood and related products, each serving specific medical purposes:
- Whole Blood: Contains all components of blood, including red blood cells, white blood cells, platelets, and plasma.
- Red Blood Cells: Also known as erythrocytes, these cells carry oxygen throughout the body.
- Plasma: The liquid portion of blood that contains important proteins for clotting and immunity.
- Platelets: Small cell fragments crucial for blood clotting.
- Clotting Factors: Proteins that help in the blood clotting process. Examples include:
- Fibrinogen: A protein that forms blood clots.
- Antifibrinolytic Agents: Medications that help prevent the breakdown of blood clots. Examples include:
- Tranexamic acid: Helps to slow down the dissolution of blood clots.
- Aminocaproic acid: Similar to tranexamic acid in its function.
- Aminomethylbenzoic acid: Another medication used to control bleeding.
- Other Blood Products: This category includes various specialized products used in specific medical situations.
Current Clinical Trial: ANNEXA-RS
A clinical trial called ANNEXA-RS is currently being conducted to study a medication called andexanet alfa. This trial is important for patients who are taking certain blood-thinning medications (specifically, Factor Xa inhibitors like apixaban, rivaroxaban, or edoxaban) and need urgent surgery.
The main goals of this study are:
- To see if andexanet alfa can effectively control bleeding during surgery
- To determine if andexanet alfa can quickly reverse the effects of blood-thinning medications
- To assess if andexanet alfa can maintain this reversal effect for a certain period after surgery
This trial compares andexanet alfa to usual care methods for managing these situations. The results could potentially improve care for patients on blood thinners who need emergency surgery.
Safety and Considerations
While blood and related products are essential in many medical situations, their use comes with some considerations:
- These products must be carefully matched to the patient to avoid adverse reactions.
- There's a small risk of transmitting infections, although modern screening methods have made this extremely rare.
- Some patients may have religious or personal objections to receiving certain blood products.
- In some cases, alternatives to blood products may be considered, depending on the specific medical situation.
Always discuss any concerns or questions about blood products with your healthcare provider. They can provide information specific to your medical situation and help you make informed decisions about your care.